Properties of mouse leukemia viruses. VII. The major viral glycoprotein of friend leukemia virus. Isolation and physicochemical properties.

PubWeight™: 2.09‹?› | Rank: Top 2%

🔗 View Article (PMID 4213320)

Published in Virology on September 01, 1974

Authors

V Moennig, H Frank, G Hunsmann, I Schneider, W Schafer

Articles citing this

Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J Virol (1983) 3.41

Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences. J Virol (1984) 3.09

Complete amino acid sequence and glycosylation sites of glycoprotein gp71A of Friend murine leukemia virus. Proc Natl Acad Sci U S A (1982) 2.06

Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. J Virol (1976) 1.56

Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54

Identification of a precursor protein to the major glycoproteins of mouse mammary tumor virus. J Virol (1975) 1.53

Biochemical and immunological characterization of the major envelope glycoprotein gp69/71 and degradation fragments from Rauscher leukemia virus. J Virol (1977) 1.37

Antibodies against the measles matrix polypeptide after clinical infection and vaccination. Infect Immun (1980) 1.33

Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proc Natl Acad Sci U S A (1977) 1.30

Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus. J Virol (1977) 1.28

Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity. J Virol (1978) 1.27

Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures. Proc Natl Acad Sci U S A (1980) 1.24

Viral protein synthesis in Friend erythroleukemia cell lines. J Virol (1977) 1.23

Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol (1996) 1.21

Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses. J Virol (1976) 1.18

Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection. J Virol (1975) 1.08

Rosettes from Friend leukemia virus envelope: preparation and physicochemical and partial biological characterization. J Virol (1979) 1.06

Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus. J Virol (1975) 1.06

Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol (1999) 1.05

Envelope polypeptides of Friend leukemia virus: purification and structural analysis. J Virol (1980) 1.03

Analysis of the envelope of Rauscher murine oncornavirus: in vitro labeling of glycopeptides. J Virol (1976) 1.03

Purification of infectious feline leukemia virus from large volumes of tissue culture fluids. J Clin Microbiol (1977) 1.01

Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins. J Virol (1975) 1.00

Isolation of the dengue virus envelope glycoprotein from membranes of infected cells by concanavalin A affinity chromatography. J Virol (1976) 0.99

Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. J Exp Med (1976) 0.98

Changes in genome composition of the Friend virus complex in erythroleukemia cells during the course of differentiation induced by dimethyl sulfoxide. Proc Natl Acad Sci U S A (1978) 0.96

Sequence analysis of Gardner-Arnstein feline leukaemia virus envelope gene reveals common structural properties of mammalian retroviral envelope genes. EMBO J (1983) 0.95

Role of carbohydrate in biological functions of Friend murine leukemia virus gp71. J Virol (1977) 0.94

Recognition of a leukemia-related antigen by an antiidiotypic antiserum to an anti-gp70 monoclonal antibody. J Exp Med (1985) 0.89

Human antibodies reactive with purified envelope antigens of primate type C tumor viruses. Proc Natl Acad Sci U S A (1978) 0.88

Radioimmunoassays for the 36,000-dalton glycoprotein of murine mammary tumor viruses demonstrate type, group, and interspecies determinants. J Virol (1979) 0.82

Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus. J Virol (1976) 0.82

Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells. J Virol (1977) 0.81

Reactivity of avian RNA tumor viruses with lectins. J Virol (1975) 0.78

Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides. EMBO J (1984) 0.75

Effect of toyocamycin on the synthesis of the 70S RNA of a murine retrovirus. Nucleic Acids Res (1979) 0.75

Articles by these authors

Cell lines derived from late embryonic stages of Drosophila melanogaster. J Embryol Exp Morphol (1972) 9.58

Autolytic enzymes and cell division of Escherichia coli. J Mol Biol (1969) 8.69

Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 8.18

THE EFFECT OF POSTURE (STANDING) ON THE SERUM PROTEIN CONCENTRATION AND COLLOID OSMOTIC PRESSURE OF BLOOD FROM THE FOOT IN RELATION TO THE FORMATION OF EDEMA. J Clin Invest (1934) 7.55

Improvement of PCR amplified DNA sequencing with the aid of detergents. Nucleic Acids Res (1990) 5.13

Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ (1987) 4.65

Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother (1998) 4.24

Genetic studies of a secondary RNA polymerase sigma factor in Bacillus subtilis. J Bacteriol (1987) 3.62

Assembly of type C oncornaviruses: a model. Science (1978) 3.53

Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J Virol (1983) 3.41

Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37

Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J Gen Virol (1987) 3.18

Identification of Plasmodium falciparum-infected mosquitoes by a double antibody enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1984) 3.00

Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet (1987) 2.98

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum. Science (1985) 2.78

Perceptions of parental bonding in borderline patients. Am J Psychiatry (1989) 2.70

Recent advances in pestivirus research. J Gen Virol (1989) 2.67

Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol (1986) 2.65

Structure of simian virus 40. II. Symmetry and components of the virus particle. Virology (1967) 2.62

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis (1997) 2.55

Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J Biol Chem (1988) 2.48

Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv Virus Res (1992) 2.41

A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother (1999) 2.40

Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans R Soc Trop Med Hyg (1984) 2.31

Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology (1972) 2.26

Structure of simian virus 40. I. Purification and physical characterization of the virus particle. Virology (1967) 2.21

Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet (1998) 2.21

Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science (1999) 2.21

Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science (1987) 2.17

Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg (1986) 2.09

Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J (1986) 2.01

An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans R Soc Trop Med Hyg (1990) 2.00

Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemagglutinating capacities. Virology (1974) 1.98

Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97

CHANGES IN THE BLOOD AND CIRCULATION WITH CHANGES IN POSTURE. THE EFFECT OF EXERCISE AND VASODILATATION. J Clin Invest (1935) 1.89

Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg (1990) 1.85

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis (1995) 1.83

Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med (1994) 1.83

Association between fulminant hepatic failure and a strain of GBV virus C. Lancet (1996) 1.82

Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis (1997) 1.79

Histology of larval eye-antennal disks and cephalic ganglia of Drosophila cultured in vitro. J Embryol Exp Morphol (1966) 1.76

[Production of substantial amounts of Friend leukemia virus by a suspension tissue culture line (Eveline suspension cells) (author's transl)]. Z Naturforsch C (1976) 1.69

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A (1995) 1.69

Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol Med (1996) 1.68

Electron microscopical studies on the localisation of the different components of cell walls of gram-negative bacteria. Folia Microbiol (Praha) (1967) 1.68

A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64

Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity. Virology (1975) 1.63

Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR. J Clin Microbiol (1998) 1.60

Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses. Virology (1973) 1.59

Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1998) 1.58

Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res (1998) 1.58

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology (1995) 1.55

Homicidal maniacs and narcissistic parasites: stigmatization of mentally ill persons in the movies. Hosp Community Psychiatry (1991) 1.53

Distribution of human endogenous retrovirus HERV-K genomes in humans and different primates. Hum Genet (1995) 1.52

Cardiac and paracardiac masses. Current opinion on diagnostic evaluation by magnetic resonance imaging. Eur Heart J (1998) 1.51

Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. N Engl J Med (1986) 1.51

vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol (1995) 1.51

Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet (1991) 1.48

Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. Virology (1975) 1.48

Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat Med (1997) 1.48

Properties of mouse leukemia viruses. X. Occurrence of viral structural antigens on the cell surface as revealed by a cytotoxicity test. Virology (1976) 1.47

Positive and negative transcriptional control by heme of genes encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase in Saccharomyces cerevisiae. Mol Cell Biol (1989) 1.44

Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol (1999) 1.43

Mass isolation of malaria sporozoites from mosquitoes by density gradient centrifugation. Proc Soc Exp Biol Med (1969) 1.43

Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology (1981) 1.43

Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei. J Clin Microbiol (1998) 1.42

Uses and misuses of oxygen in hospitalized patients. Am J Med (1992) 1.41

Congenital malformations of the right atrium and the coronary sinus: an analysis based on 103 cases reported in the literature and two additional cases. Chest (2000) 1.41

[Disseminated cicatricial pemphigoid]. Hautarzt (1991) 1.39

C-type particles produced by a permanent cell line from a leukemic pig. I. Origin and properties of the host cells and some evidence for the occurrence of C-type-like particles. Virology (1974) 1.38

Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. Virology (1975) 1.37

Lymphogenic haemangiopathy. "Prelymphatic" pathways in the wall of cerebral and cervical blood vessels. Angiologica (1968) 1.37

Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol (1984) 1.36

Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg (1993) 1.34

Effect of medium conductivity and composition on the uptake of propidium iodide into electropermeabilized myeloma cells. Biochim Biophys Acta (1996) 1.32

Creatine improves health and survival of mice. Neurobiol Aging (2007) 1.31

Epidemiology of classical swine fever in Germany in the 1990s. Vet Microbiol (2000) 1.30

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol (1989) 1.30

Neutralizing antibodies and the course of HIV-induced disease. AIDS Res Hum Retroviruses (1987) 1.29

Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli. Exp Parasitol (1987) 1.29

Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol (1996) 1.27

Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab (1997) 1.26

Properties of mouse leukemia viruses. XI. Immunoelectron microscopic studies on viral structural antigens on the cell surface. Virology (1976) 1.25

Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J Virol (1999) 1.24

Monoclonal antibodies with neutralizing activity segregate isolates of bovine viral diarrhea virus into groups. Brief report. Arch Virol (1988) 1.23

Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques. Genes Immun (2007) 1.22

Evolution of canine information processing under conditions of natural and artificial selection. Z Tierpsychol (1980) 1.21

Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS Res Hum Retroviruses (1994) 1.20

Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J Virol (1997) 1.20

ELISA method for detecting Plasmodium falciparum circumsporozoite antibody. Bull World Health Organ (1989) 1.20

Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Brain Res Mol Brain Res (1995) 1.20

Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) (1986) 1.20